Phase II Trial of Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC)
The purpose of this phase II study is to learn if Niraparib can help to control metastatic pancreatic cancer. The safety of this drug will also be studied.
Study ID: IIT-2017-NIRA-PANC
Trial Phase: Phase II
Trial Sponsor: University of Kansas Medical Center, Tesaro
Therapies Used in This Trial: Niraparib